Please assess the completion status of the following clinical trial:

Trial Title: Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Medical history of gastric and/or duodenal ulcer~* A diagnosis of a chronic condition (rheumatoid arthritis, osteoarthritis, lumbago,etc) that requires daily NSAID use,at least 20 years of age~Exclusion Criteria:~* Having gastric or duodenal ulcer in active or healing stage according to the Sakita/Miwa classification~* History of esophageal, gastric or duodenal surgery~* Having severe liver disease or chronic renal disease

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): Placebo
- 2 (Type: EXPERIMENTAL): Esomeprazole 20 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).